HUM NYSE Week ended 24 Jul 2026

Weekly Investor Report

Humana Inc · Healthcare · Healthcare Plans

Open interactive chart View report data Download investor PDF
Latest close 389.3 USD
-2.7% latest week
Weekly setup

Constructive, but selective

The weekly trend is active. Price is 46.6% above the Trend Line and sits at 85.2% of its 52-week range. The latest completed week returned -2.7%, after a 1.4% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks weakly; valuation is expensive relative to peers. Options positioning is volatility with 45/100 conviction, while the latest news-sentiment score is 52/100. Near-term considerations: volume confirmation is below normal.

Setup score 62 out of 100
Latest Close 389.3 USD 24 Jul 2026
1W Return -2.7% latest completed week
4W Return 1.4% short-term follow-through
12W Return 67.0% quarterly tape
Trend Breadth 38.5% 20 of 52 weeks active
Volume Ratio 0.6x vs 13-week average
What is working
  • The trend backdrop is active with a 8-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • No major top-level risk cluster is currently dominant.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -2.7% Latest completed week; four-week move 1.4%. Indicator stack 49/66 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Options pressure Volatility 45/100 conviction; expected move 8.4%. News sentiment 52/100 56 relevant articles in the latest sentiment read. Event risk 29 Jul Latest stored earnings date was 29 Jul 2026.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 46.6% above the Trend Line and sits at 85.2% of its 52-week range. The latest completed week returned -2.7%, after a 1.4% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.6x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.8912-week average 0.57

12-week confirmation

Trend active8/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.89Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 1.4% over four weeks, 67.0% over 12 weeks, and 65.6% over one year. The current trend has remained active for 8 consecutive weeks.

Performance by holding period

1W-2.7%
4W1.4%
12W67.0%
26W46.9%
52W65.6%
Active trend streak8 weeks
Active weeks in one year20
Trend breadth38.5%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.94Latest activity-pressure read.
Pressure change-16.5%Four-week change in activity pressure.
Leadership36.32Latest relative-leadership reading.
RS change-10.8%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks weakly; valuation is expensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Dec 2025 Field coverage 100% Model confidence 96%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength19/100Blend of value, momentum, and quality. Underlying universe rank 82; rank 1 is best.
Value17/100Relative valuation strength. Underlying universe rank 84; rank 1 is best.
Quality17/100Profitability and accounting quality. Underlying universe rank 84; rank 1 is best.
Momentum90/100Medium-term price momentum. Underlying universe rank 11; rank 1 is best.
Growth8/100Revenue and earnings growth. Underlying universe rank 93; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework34/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
41.4x
Price divided by trailing earnings.
Price / sales
0.3x
Market value relative to trailing revenue.
EV / EBITDA
19.6x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
4.3%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
14.0%
Gross profit retained from each unit of revenue.
Operating margin
1.5%
Operating profit retained from revenue.
Free-cash-flow margin
1.8%
Free cash flow generated from revenue.
Return on invested capital
6.1%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
14.1%
Latest one-year revenue growth.
EPS growth
-33.9%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-28.2%
Latest one-year free-cash-flow growth.
Piotroski F-score
5/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
0.9%
Cash dividends relative to market value.
Buyback yield
0.5%
Net share repurchases relative to market value.
Shareholder yield
1.4%
Dividend yield plus net buyback yield.
Net debt / EBITDA
3.2x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningVolatility

HUM shows volatility options pressure with a 45/100 conviction score, put-call volume ratio of 1.39, expected move of 8.4%, and Sharemaestro trend signal active.

Conviction45/100
Expected move8.4%
Put/call volume1.39
Pressure-16
Speculation42
Volatility90
Trend agreement77
Open options detail
Insider activity12 / 2

12 acquisitions and 2 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment52/100

Weighted news tone is neutral across 56 relevant articles.

18 positive · 31 neutral · 7 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings29 JulLatest stored earnings date was 29 Jul 2026.
Options expected move8.4%Nearest-chain priced movement where available.
52-week drawdown-9.2%Distance below the 52-week high.
13-week volatility6.6%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher17 of 269 weeks finished lower.
Best week+17.7%Week of 8 May.
Worst week-26.8%Week of 30 Jan.
Latest week-2.7%Week of 24 Jul.

Shape of recent returns

Strong gains10
Modest gains7
Flat weeks0
Modest losses4
Sharp losses5
Recent vol6.6%13-week weekly-return volatility.
Base vol7.1%52-week weekly-return volatility.
Up/down split32/20Count of positive and negative weeks in the 52-week window.
Average skew5.4% / -5.4%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape57/100

Trend, activity pressure, participation, and risk combine to a 57/100 tape read.

 Indicator analysis81/100

Latest 12-week confirmation: trend 8/12, activity pressure 12/12, relative leadership 12/12.

Activity pressure 0.89; No reversal markers Factors32/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 35 SVQF34/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 668.0 of 1013 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options55/100

HUM shows volatility options pressure with a 45/100 conviction score, put-call volume ratio of 1.39, expected move of 8.4%, and Sharemaestro trend signal active.

Volatility · Volatility expansion watch · Expected move 8.4% Sentiment52/100

Weighted news tone is neutral across 56 relevant articles.

Humana Earnings Face High Expectations as Medicare Advantage Recovers Insiders12 / 2

12 acquisitions and 2 disposals in the latest 180-day insider tape.

 Earnings29 Jul

Latest stored earnings date was 29 Jul 2026.

 Research flow4 items

1 recent research articles and 3 Market Watch posts are available.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
24 Jul 2026389.3 USD-2.7%265.6 USD311.9 USD0.9436.324.4MOn
17 Jul 2026400.0 USD2.0%261.2 USD312.2 USD1.0640.318.0MOn
10 Jul 2026392.2 USD-1.1%256.5 USD312.5 USD1.0736.746.4MOn
3 Jul 2026396.8 USD3.4%252.2 USD312.7 USD1.0841.295.9MOn
26 Jun 2026383.8 USD6.7%247.5 USD312.8 USD1.1340.727.8MOn
19 Jun 2026359.8 USD-4.9%242.9 USD313.1 USD1.0529.678.5MOn
12 Jun 2026378.3 USD8.3%238.4 USD313.5 USD1.0038.195.6MOn
5 Jun 2026349.3 USD14.6%233.6 USD313.9 USD1.0929.097.6MOn
29 May 2026304.7 USD-0.8%230.3 USD314.8 USD1.0710.333.6MOff
22 May 2026307.2 USD0.9%229.3 USD316.1 USD1.0812.916.7MOff
15 May 2026304.4 USD11.0%228.7 USD317.2 USD0.8913.0012.5MOff
8 May 2026274.3 USD17.7%227.6 USD318.4 USD0.472.128.1MOff
1 May 2026233.1 USD8.5%227.8 USD319.9 USD0.08-11.5112.0MOff
24 Apr 2026214.7 USD4.7%229.4 USD321.7 USD-0.45-18.278.5MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.